Cytokinetics | CYTK - Stock


Cytokinetics reported $0 in Stock for its fiscal quarter ending in December of 2023.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cytokinetics USD 0 0 Dec/2023
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Exelixis USD 27.4M 3.92M Sep/2025
Geron USD 116.64M 21.21M Dec/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025